DSM-Firmenich

DSFIR

CH1216478797

DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.

Employees

27,926

Sector

Consumer Goods Conglomerates

Calendar

2025-02-13 - Q4 2024 Earnings Release

More about the company

Income Statement and Estimates

income-statement-evolution-chart DSM-FIRMENICH

More financial data

Analysis / Opinion

DSM-FIRMENICH : Vitamin shortage plays into the management's hands

November 03, 2024 at 03:02 pm

More Strategies

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

103.80EUR

Average target price

128.96EUR

Spread / Average Target

+24.24%

Consensus

Profit revisions

Estimate revisions

Quarterly revenue - Rate of surprise

Company calendar

End-of-day quote Euronext Amsterdam Other stock markets 2024-12-09			5-day change	1st Jan Change
103.80 ^CHF	-0.43%		-0.95%	+12.83%

11-21	Robertet: Fonds Stratégique de Participations tops 5% mark	CF
11-21	DSM-Firmenich Exits Stake in Fragrances, Flavors Company Robertet	MT

Robertet: Fonds Stratégique de Participations tops 5% mark	11-21	CF
DSM-Firmenich Exits Stake in Fragrances, Flavors Company Robertet	11-21	MT
Dsm-Firmenich Sells Majority of Robertet Stake	11-15	MT
Robertet: change in shareholder base	11-15	CF
DSM-FIRMENICH : Vitamin shortage plays into the management's hands	11-03
Global markets live: Blackstone, Coinbase, MetLife, Airbus, Shell...	10-31
DSM-Firmenich AG, Q3 2024 Sales/ Trading Statement Call, Oct 31, 2024	10-31
DSM-Firmenich Obtains SBTi Certification for Greenhouse Gas Emission Reduction Targets	10-24	MT
Symrise on track after growth - growth target specified	10-24	RE
DSM-Firmenich Closes Divestment of Yeast Extract Business	10-02	MT
Lesaffre et Compagnie, SA completed the acquisition of Yeast Extract Business of DSM-Firmenich.	10-01	CI
Global markets live: Nokia, Amgen, Amazon, Verizon, Rio Tinto...	10-01
DSM-Firmenich Closes Sale of MEG-3 Fish Oil Business to KD Pharma	10-01	MT
KD Pharma Group SA completed the acquisition of MEG-3® fish oil business of dsm-firmenich from DSM-Firmenich AG.	09-30	CI
DSM-Firmenich AG Presents at Deutsche Bank?s Depositary Receipts Virtual Investor Conference, Sep-25-2024 11:30 AM	09-25
Kepler Cheuvreux Upgrades DSM-Firmenich to Buy, Boosts PT	08-30	MT
DSM-FIRMENICH : Vitamins strong final chord	08-13
DSM-Firmenich Obtains EUR1.8 Billion Syndicated Revolving Credit Facility	08-08	MT
DSM-Firmenich Concludes New ?1.8 Billion Revolving Credit Facility	08-08	CI
DSM-FIRMENICH : EPS upgrade (2024: +10.0%, 2025: +2.4%)	08-05
Indices: Guinness and chips, same battle	07-31
Global markets live: Diageo, Apple, Tesla, Meta Platforms, PayPal, Pfizer...	07-30
DSM-FIRMENICH : Guidance lifted after a strong Q2	07-30
DSM-Firmenich AG, H1 2024 Earnings Call, Jul 30, 2024	07-30
DSM-Firmenich AG Reports Earnings Results for the Half Year Ended June 30, 2024	07-30	CI

DSM-Firmenich

Equities